Redhill Biophrma ADR (RDHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Sales | 1 | 3 | 4 | 4 | 4 |
| Gross Profit | -1 | 3 | 4 | 4 | 4 |
| Operating Expenses | 3,510 | 2,740 | 2,520 | 2,010 | 0 |
| Operating Income | -3,509 | -2,737 | -2,516 | -2,006 | 4 |
| Interest Expense | 1 | 3 | 3 | 3 | 0 |
| Other Income | 60 | 50 | 9 | 39 | 0 |
| Pre-tax Income | -3,450 | -2,690 | -2,510 | -1,970 | 4 |
| Net Income Continuous | -3,440 | -2,699 | -2,512 | -1,977 | -3,352 |
| Net Income | $-3,440 | $-2,699 | $-2,512 | $-1,977 | $-3,352 |
| EPS Basic Total Ops | -500.00 | -430.00 | -400.00 | -300.00 | -700.00 |
| EPS Basic Continuous Ops | -537.50 | -428.41 | -405.16 | -299.55 | -632.45 |
| EPS Diluted Total Ops | -500.00 | -430.00 | -400.00 | -300.00 | -700.00 |
| EPS Diluted Continuous Ops | -537.50 | -428.41 | -405.16 | -299.55 | -632.45 |
| EBITDA(a) | $-3,499 | $-2,737 | $-2,512 | $-2,000 | $4 |